These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 27129167)

  • 21. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
    Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic Impact of 1q21 Amplification in Newly Diagnosed Multiple Myeloma Patients Receiving Bortezomib-Based First-Line Treatment].
    Deng P; Zhou YL; Wei YL; Li P; Li F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1696-1701. PubMed ID: 29262900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib.
    Smetana J; Berankova K; Zaoralova R; Nemec P; Greslikova H; Kupska R; Mikulasova A; Frohlich J; Sevcikova S; Zahradova L; Krejci M; Sandecka V; Almasi M; Kaisarova P; Melicharova H; Adam Z; Penka M; Jarkovsky J; Jurczyszyn A; Hajek R; Kuglik P
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):123-30. PubMed ID: 23291040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on the Association Between miRNA-202 Expression and Drug Sensitivity in Multiple Myeloma Cells.
    Shen X; Guo Y; Qi J; Shi W; Wu X; Ni H; Ju S
    Pathol Oncol Res; 2016 Jul; 22(3):531-9. PubMed ID: 26689580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
    Zhang H; Du Z; Tu C; Zhou X; Menu E; Wang J
    Cancer Res; 2024 Jan; 84(1):39-55. PubMed ID: 37756570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.
    Li F; Xu Y; Deng P; Yang Y; Sui W; Jin F; Hao M; Li Z; Zang M; Zhou D; Gu Z; Ru K; Wang J; Cheng T; Qiu L
    Oncotarget; 2015 Apr; 6(11):9434-44. PubMed ID: 25831238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.
    Wang X; Qian T; Bao S; Zhao H; Chen H; Xing Z; Li Y; Zhang M; Meng X; Wang C; Wang J; Gao H; Liu J; Zhou M; Wang X
    Mol Oncol; 2021 Sep; 15(9):2466-2479. PubMed ID: 34058065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
    Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP
    Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-520g and miR-520h overcome bortezomib resistance in multiple myeloma via suppressing APE1.
    Yuan X; Ma R; Yang S; Jiang L; Wang Z; Zhu Z; Li H
    Cell Cycle; 2019 Jul; 18(14):1660-1669. PubMed ID: 31204563
    [No Abstract]   [Full Text] [Related]  

  • 32. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
    Soley L; Falank C; Reagan MR
    Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microenvironment drug resistance in multiple myeloma: emerging new players.
    Di Marzo L; Desantis V; Solimando AG; Ruggieri S; Annese T; Nico B; Fumarulo R; Vacca A; Frassanito MA
    Oncotarget; 2016 Sep; 7(37):60698-60711. PubMed ID: 27474171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of serum exosome isolation methods for microRNA profiling.
    Rekker K; Saare M; Roost AM; Kubo AL; Zarovni N; Chiesi A; Salumets A; Peters M
    Clin Biochem; 2014 Jan; 47(1-2):135-8. PubMed ID: 24183884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.